professional documents
home
Upload
docsters
Upload

search results


Non Disclosure Agreement - Boilerplate

cqconsult 8/5/2007 | 6 (2) | 2239 | 308 | 1 | English

Non Disclosure Agreement  ... more>>

NDA S and S NDA S and S - detailed view

FDADocs 5/9/2008 | 0 (0) | 64 | 0 | 0 | English

NDA 50-710/S-017 and S-021 NDA 50-711/S-015 and S-017 Page 370-5179-00-1.1ZITHROMAX??(azithromycin tablets) and (azithromycin for oral suspension)DESCRIPTION ZITHROMAX?? (azithromycin  ... more>>

NDA for Evaluation

anonymous 1/4/2008 | 0 (0) | 387 | 35 | 0 | English

??? 1 ??? COMPANY NAME [ADDRESS] [ADDRESS] _______________, 200_ CONFIDENTIAL Company /Person Name. [ADDRESS] [ADDRESS] Tel: Email: Attention: [NAME] Dear [NAME]: Confidentiality a...  ... more>>

legal > Forms >

NDA

anonymous 4/14/2008 | 0 (0) | 140 | 5 | 0 | English

MUTUAL NON-DISCLOSURE AGREEMENT THIS AGREEMENT governs the disclosure of information by and between and as of Date"). 1. Definition of Confidential Information. As used herein, "Co...  ... more>>

AZ NDA

jasinhollis 9/5/2008 | 0 (0) | 109 | 3 | 0 | English

NDA S NDA S and NDA S Page - detailed view

FDADocs 5/9/2008 | 0 (0) | 47 | 0 | 0 | English

NDA 20-406/S-057, NDA 21-281/S-014, and NDA 21-428/S-004 Page 3(Nos. 1541, 1543, 1544, 3046, 7309, 7311) TAPDN198-V1; Rev. Month, Year TAPDN198-V2; Rev. Month, YearPREVACID??(lansoprazole  ... more>>

NDA S NDA S NDA S Page ZITHROMAX detailed view

FDADocs 5/9/2008 | 0 (0) | 57 | 0 | 0 | English

NDA 50-710/S-023 NDA 50-711/S-019 NDA 50-784/S-007Page 3ZITHROMAX??(azithromycin tablets) and (azithromycin for oral suspension)To reduce the development of drug-resistant bacteria and  ... more>>

NDA S NDA S NDA S Page Agouron detailed view

FDADocs 5/9/2008 | 0 (0) | 38 | 0 | 0 | English

NDA 20-778/S-025 NDA 20-779/S-046 NDA 21-503/S-007 Page 3423-6004-00-7Agouron Pharmaceuticals, Inc. VIRACEPT?? Patient Prescribing Information [logo] VIRACEPT?? (nelfinavir mesylate) TABLETS  ... more>>

NDA S NDA S NDA S Page PEPCID detailed view

FDADocs 5/9/2008 | 0 (0) | 46 | 0 | 0 | English

NDA 19-462/S-034 NDA 19-510/S-031 NDA 20-249/S-013 Page 13PEPCID??(FAMOTIDINE) INJECTION PREMIXED PEPCID?? (FAMOTIDINE) INJECTIONDESCRIPTION The active ingredient in PEPCID* (famotidine  ... more>>

NDA - Non Disclosure Agreement

anonymous 6/15/2007 | 6.7 (24) | 22336 | 1859 | 5 | english

non-disclosure confidentiality forms  ... more>>

Information Exchange Agreement

mw 10/11/2007 | 0 (0) | 862 | 44 | 0 | English

Similar to an NDA, but for partnerships  ... more>>

NDA S NDA S NDA S Page PEPCID

GovernmentDocs 5/5/2008 | 0 (0) | 32 | 0 | 0 | English

NDA 19-462/S-034 NDA 19-510/S-031 NDA 20-249/S-013 Page 13PEPCID??(FAMOTIDINE) INJECTION PREMIXED PEPCID?? (FAMOTIDINE) INJECTIONDESCRIPTION The active ingredient in PEPCID* (famotidine  ... more>>

NDA S detailed view

FDADocs 5/9/2008 | 0 (0) | 24 | 0 | 0 | English

NDA 20-154/S-050 NDA 20-155/S-039 NDA 20-156/S-040 NDA 21-183/S-016Patient InformationRx onlyVIDEX??(generic name = didanosine also known as ddI)VIDEX (didanosine) Pediatric Powder for  ... more>>

Standard NDA for Tech Firms

mw 10/11/2007 | 8 (7) | 4207 | 410 | 2 | English

A free standard non-disclosure agreement geared for use at technology companies.  ... more>>

NDA NDA Page by CFR part A general

FDADocs 5/8/2008 | 0 (0) | 27 | 0 | 0 | English

NDA 20-732 NDA 20-733 Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose.Information for PharmacistsSUBOXONE  ... more>>


   
  results / page   15/25/50 Page: 2 of 32 << prev 12345...32 next >>